<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03203122</url>
  </required_header>
  <id_info>
    <org_study_id>REG-115-2016</org_study_id>
    <nct_id>NCT03203122</nct_id>
  </id_info>
  <brief_title>Intense Pulsed Light Therapy for Hidrosadenitis Suppurativa</brief_title>
  <official_title>The Effect of Intense Pulsed Light Assisted Hair Removal Therapy on Mild and Moderate Cases of Hidrosadenitis Suppurativa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zealand University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      6 monthly treatments with IPL laser in patients with Hidradenitis Suppurativa. The effect in
      measured on several severity scores.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patient suffering from bilateral HS in the axilla or groin area are threated with IPL laser
      monthly for 6 months.

      Patients are randomized to treatment in either left or right side, the other side works as
      control.

      No sham treatment, but observers are blinded.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 7, 2017</start_date>
  <completion_date type="Anticipated">August 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients are randomized to treatment in either left or right side, using the other side as control.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Outcome assesor and primary invstigator are blinded and not present at treatments.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>HiScore</measure>
    <time_frame>After 6 treatments i.e. 6 months</time_frame>
    <description>50 % reduction in abcesses and draining fistual</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sartorius score</measure>
    <time_frame>after 6 treatments i.e. 6 months</time_frame>
    <description>HS severity score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physician global assesment</measure>
    <time_frame>after 6 treatments i.e. 6 months</time_frame>
    <description>HS severity score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hidradenitis Suppurativa</condition>
  <condition>Acne Inversa</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients are randomized to treatment of either right or left side. The other side works as control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Patients are randomized to treatment in either right or left side. The other side works as control</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IPL laser</intervention_name>
    <description>IPL laser monthly. Vertical and horizontal treatment, one pass over. Settings according to fitzpatrick skin type</description>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No sham treatment</intervention_name>
    <description>The treatment is slightly painful, and noisy. Sham treatment impossible</description>
    <arm_group_label>Comparator Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bilateral HS in the axilla or groin area

          -  Fitzpatrick skin type I-II

        Exclusion Criteria:

          -  Pregnant

          -  Unable to understand or communicate with study personnel
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Peter Riis, MD</last_name>
    <phone>47322672</phone>
    <email>pmik@regionsjaelland.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gregor Jemec, DMSc</last_name>
    <email>gbj@reg√≠onsjaelland.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University hospital Zealland</name>
      <address>
        <city>Roskilde</city>
        <zip>4000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter T Riis, MD</last_name>
      <phone>47322672</phone>
      <email>pmik@regionsjaelland.dk</email>
    </contact>
    <contact_backup>
      <last_name>Linnea Thorlacius, MD</last_name>
      <phone>47322671</phone>
      <email>lrit@regionsjaelland.dk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2017</study_first_submitted>
  <study_first_submitted_qc>June 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2017</study_first_posted>
  <last_update_submitted>June 28, 2017</last_update_submitted>
  <last_update_submitted_qc>June 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hidradenitis</mesh_term>
    <mesh_term>Hidradenitis Suppurativa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Will not be shared</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

